$CTSH

ROHLEDER STEPHEN J purchased $210K of CTSH

ROHLEDER STEPHEN J purchased 4,034 shares of COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH) at $52.00 ($0.21M total) on 2026-06-10.

Original reporting
SEC EDGAR · ROHLEDER STEPHEN J
Published Jun 12, 2026, 8:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 12, 2026, 8:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CTSH
Bullish
low confidence
Mentioned
$CTSH
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTSHBullishLow
01

Why it matters

The disclosure updates insider ownership records and may slightly influence sentiment, but it does not introduce new company fundamentals.

02

Market read

Traders may note the insider buy as a small bullish datapoint, but it is unlikely to drive a sustained repricing without additional catalysts.

03

What to watch

No 10b5-1 plan is cited, but the article also provides no context on prior holdings, intent, or whether the purchase is part of a broader pattern.

Relevance 5/10Novelty 5/10Timing: Filed 2026-06-12; transaction dated 2026-06-10.

Background

The article is an SEC Form 4 insider transaction disclosure from Cognizant’s director.

Company-level read

Ticker impact

$CTSHBullishLow confidence
Context

SEC Form 4 shows director Stephen J. Rohleder bought 4,034 shares of Cognizant (CTSH) for ~$209,768 on 2026-06-10.

Expected impact

Likely limited near-term impact; any effect is more sentiment/positioning than fundamentals.

Evidence & confidence

The filing is primary-source insider activity, but the disclosed size is small relative to typical daily liquidity and there is no accompanying company-specific news (guidance, contract, legal/regulatory action).

Market effects

No clear sector read-through; this is company-specific insider buying without new operational information.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine (compensation diversification, personal liquidity planning) and may not reflect near-term business outlook.

Key entities

  • CTSH

    Cognizant Technology Solutions Corp; subject of the Form 4 insider purchase.

  • ROHLEDER STEPHEN J

    Director who purchased 4,034 shares open-market on 2026-06-10.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CTSHMedAI 8/10

Cognizant's AI Gamble: What Nearshore Must Learn

Cognizant reported Q2 2026 revenue growth of 4.5%, down from Q2 2025, but beat peers and met guidance. Bookings fell 6% YoY. The company raised full-year EPS guidance to $5.70-$5.82, and its stock surged 41.81% in a month. Cognizant cited AI-led demand and partnerships with Google Cloud and Anthropic.

$CTSHMed

Anthropic Is Only Part of the Story. Cognizant Has a Much Bigger AI Plan.

Cognizant (CTSH) trades at a discount versus its historical valuation, with forward GAAP P/E of 8.31x and P/S of 0.97x. In Q2, it reported EPS $1.37 vs $1.38 expected, 4.5% revenue growth, and $459M free cash flow. Management guided Q3 growth 3.8%-5.3% YoY and FY EPS to $5.76 midpoint. Guggenheim cut its price target to $65 but kept a Buy; analysts’ mean target is $60.12.

$CTSHMedAI 8/10

Cognizant Technology Solutions Corporation Q2 2026 Earnings Call Summary

Cognizant Technology Solutions reported 4.1% year-over-year constant-currency revenue growth in Q2 2026, driven by North America and 12% growth in financial services. The company revised full-year revenue guidance to 4% to 5.5% growth and kept adjusted operating margin at 16% to 16.2%. It cited an $81M one-time India benefit, Project LEAP costs, and interest expense after a $1B Astreya-related draw.

$CTSHMed

Cognizant Earnings: Financial Services and North America Drive Resilient Performance

Morningstar’s stock note says Cognizant (CTSH) reported 4% Q2 constant-currency revenue growth, with operating margin steady at 16% and trailing 12-month bookings up 5%. It attributes results to North America and financial services, where growth was 12%. Morningstar keeps a $84 fair value estimate and 16.0%-16.2% operating margin guidance, while trimming full-year revenue growth outlook to 4.0%-5.5%.